Article Versions Notes

Liu F, Alfarhan M, Baker L, Shenoy N, Liao Y, Henry-Ojo HO, Somanath PR, Narayanan SP. Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells. 2022; 11(24):4100. https://doi.org/10.3390/cells11244100

Liu, Fang, Moaddey Alfarhan, Leanna Baker, Nidhi Shenoy, Yini Liao, Harry O. Henry-Ojo, Payaningal R. Somanath, and S. Priya Narayanan. 2022. "Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis" Cells 11, no. 24: 4100. https://doi.org/10.3390/cells11244100

Liu, F., Alfarhan, M., Baker, L., Shenoy, N., Liao, Y., Henry-Ojo, H. O., Somanath, P. R., & Narayanan, S. P. (2022). Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells, 11(24), 4100. https://doi.org/10.3390/cells11244100